catalyst
as of 2026-07-01Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Ho — primary completion
at a glance
2027-07-29 · Estimated (est.) — Registry-estimated date, not yet actual.
Synthesized from structured facts only — each point cited above.
Event
What
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Ho — primary completion
Type
Trial Readout
Date
2027-07-29
Date type
ESTIMATED est.
Phase
Phase 2
Registry-estimated date, not yet actual. This date is directional and must not be read as settled.
relationships
The graph out of here